Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease
Clinical trial NCT02225132 · COMPLETED
Trial details
- NCT number
- NCT02225132
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-23
- Primary completion
- 2018-05-24
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.